Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
|
|
34.
|
|
|
35.
|
A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours. [electronic resource] by
- Papadopoulos, K P
- El-Rayes, B F
- Tolcher, A W
- Patnaik, A
- Rasco, D W
- Harvey, R D
- LoRusso, P M
- Sachdev, J C
- Abbadessa, G
- Savage, R E
- Hall, T
- Schwartz, B
- Wang, Y
- Kazakin, J
- Shaib, W L
Producer: 20171205
In:
British journal of cancer vol. 117
Availability: No items available.
|
|
36.
|
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas. [electronic resource] by
- Patnaik, A
- Appleman, L J
- Tolcher, A W
- Papadopoulos, K P
- Beeram, M
- Rasco, D W
- Weiss, G J
- Sachdev, J C
- Chadha, M
- Fulk, M
- Ejadi, S
- Mountz, J M
- Lotze, M T
- Toledo, F G S
- Chu, E
- Jeffers, M
- Peña, C
- Xia, C
- Reif, S
- Genvresse, I
- Ramanathan, R K
Producer: 20171222
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|